# SDP Japan

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sdp-japan

- Industry: Outsourcing
- Headquarters: Tokyo, Japan
- Website: www.sdp-japan.com
- Latest round: Series D (Jun 16, 2025)
- Investors on record: 7

## About

Based in Japan, SDP Japan, Inc. is engaged in the production and management of advanced medical services, particularly focusing on enhancing surgical procedures and patient care through strategic partnerships with healthcare institutions.SDP Japan, Inc., founded in 2014 and headquartered in Tokyo, Japan, specializes in advanced medical services. The company has executed a total of 7 deals since its inception. Its latest funding round includes a SERIES C raise of JPY 252.000 mn from Mitsubishi Estate, bringing the total amount raised to JPY 252.000 mn, with a current company valuation of JPY 9,894.529 mn.SDP Japan specializes in the comprehensive production and management of advanced medical services, particularly focusing on the Super Doctor Production business. Their core offerings include collaboration in the procurement of medical materials and partnerships with specialized healthcare institutions, emphasizing high-level surgical procedures. SDP Japan serves a diverse client base encompassing healthcare providers, medical professionals, and patients, particularly in metropolitan areas such as Tokyo and Osaka, and extends its connections to international medical entities.In 2017, SDP Japan reported a revenue of JPY 13,058,676, structured around partnerships and collaborations with healthcare facilities. The company engages in business-to-business transactions, facilitating access to specialized medical resources and expertise through contractual agreements. Their flagship services are instrumental in enhancing operational efficiencies and patient care within partner institutions, showcasing a focus on building long-lasting relationships and generating steady income through specialized offerings.In June 2025, SDP Japan, Inc. raised an undisclosed amount in SERIES D funding, led by Japan Post Investment Corporation, with participation from other investors. This round is part of a larger JPY 4.5 billion SERIES D equity and debt funding, which will be utilized to expand support services for healthcare institutions and facilities. The company aims to introduce new products and further develop its service offerings, specifically targeting expansions into new markets and geographic regions.

## Funding rounds

- Series D, Jun 16, 2025 — Sumitomo Mitsui Trust Bank, Globis Capital Partners, Eight Roads Ventures, Sumitomo Mitsui Trust Investment, Japan Post Investment Corporation, Spiral Capital, Toda

## Investors

- Sumitomo Mitsui Trust Bank — Series D
- Globis Capital Partners (https://capitalatlas.ai/funds/globis-capital-partners) — Series D
- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series D
- Sumitomo Mitsui Trust Investment (https://capitalatlas.ai/funds/sumitomo-mitsui-trust-investment) — Series D
- Japan Post Investment Corporation — Series D
- Spiral Capital (https://capitalatlas.ai/funds/spiral-capital) — Series D
- Toda — Series D
